Terms: = Endocrine gland cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Staging
4 results:
1. Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term prognosis in a high-volume center.
Zhang XP; Xu S; Zhao ZM; Liu Q; Zhao GD; Hu MG; Tan XL; Liu R
Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):140-146. PubMed ID: 36171169
[TBL] [Abstract] [Full Text] [Related]
2. Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR).
Trédan O; Provansal M; Abdeddaim C; Lardy-Cleaud A; Hardy-Bessard AC; Kalbacher E; Floquet A; Venat-Bouvet L; Lortholary A; Pop O; Frenel JS; Cancel M; Largillier R; Louvet C; You B; Zannetti A; Anota A; Treilleux I; Pissaloux D; Houlier A; Savoye AM; Mouret-Reynier MA; Meunier J; Levaché CB; Brocard F; Ray-Coquard I
Gynecol Oncol; 2022 Jan; 164(1):18-26. PubMed ID: 34696892
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head.
Wu C; Hou SZ; Wu Z; Huang X; Wang Z; Tian B
BMC Cancer; 2021 May; 21(1):624. PubMed ID: 34044806
[TBL] [Abstract] [Full Text] [Related]
4. Fusion imaging in preoperative assessment of extent of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings.
Moro F; Bertoldo V; Avesani G; Moruzzi MC; Mascilini F; Bolomini G; Caliolo G; Esposito R; Moroni R; Zannoni GF; Fagotti A; Manfredi R; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2021 Dec; 58(6):916-925. PubMed ID: 33847427
[TBL] [Abstract] [Full Text] [Related]
